Saxenda is a GLP-1 receptor agonist that slows gastric emptying to promote satiety and weight loss
Ohio State Health and Discovery: Taking a GLP-1
Personalized Treatment Plan: Based on Sarahs consultation, blood work, and body composition results, we identify she has low testosterone levels, elevated cortisol (indicative of stress), and insulin resistance
1 The company is positioning the move as a direct response to structural cost issues in the current system, which, as Arpit Patel, senior vice president of Trade Relations and Supply Chain, noted, remains unnecessarily complex and expensive. 1 This move comes at a time when 2 The financial pressure on employer health plans has intensified as GLP-1 medications move from being primarily used for type 2 diabetes to widespread use for weight management
185,186,187,188 In the future, GLP-1R agonists may benefit all patients with metabolic cardiovascular risk by slowing the progression of cardiac remodeling, thereby reducing cardiovascular risk